Log in using OpenID

DNA Chip Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020

A DNA chip, also referred to as a DNA microarray, is comparable to a computer chip. The key differentiating factor between the two is that a computer chip is imbedded with electronic circuitry, whereas a DNA gene chip is imbedded with DNA molecules.
Single User License:
DNA Chip Market - Global Industry
Analysis, Size, Share, Growth,
Trends And Forecast 2014 - 2020
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
[email protected]
USD 4315.5
Flat 10% Discount!!
Report will be delivered with in 15-20 working days
Free Customization as per your requirement
You will get Custom Report at Syndicated Report
Request Sample
Buy Now
A DNA chip, also referred to as a DNA microarray, is comparable to a computer chip.
differentiating factor between the two is that a computer chip is imbedded with electronic
whereas a DNA gene chip is imbedded with DNA molecules. Or else it can be stated that DNA
collection of DNA spots that are embedded on the solid surface. A DNA gene chip is about the
postage stamp. This technology has become very popular in the drug discovery and medical
sector as it significantly brings down research time.
The key
chip is a
size of a
Browse Full Report with TOC @
DNA microarrays play a vital role in helping medical researchers simultaneously measure the expression
levels of several thousands of genes. The spiraling popularity of DNA chips has prompted many new
players to enter the market and profit from their growing demand. In view of these aspects, the market for
DNA gene chips is projected to show double-digit growth over the forecast period of this report. This
technology is used to measure the expression levels of thousands of gene together at the same time.
Based on type, DNA gene chip market can be split into oDNA (oligonucleotide DNA) and cDNA
(complementary DNA). The former is a dominant segment in the market, accounting for over 95% of the
overall market share. The DNA gene chip market can also be classified by application as: comparative
genomic hybridization, gene expression profiling, geneID, and others. The gene expression market
emerges as the largest owing to its extensive applications in agriculture, clinical diagnostics, and other
emerging sectors. This segment will likely demonstrate healthy growth over the forecast period as a result
of substantial funding from governments and private players alike.
The report studies the DNA gene chip market based on geography by classifying it as: North America,
Europe, Asia Pacific, and others. While North America was the dominant market in this sector until a few
years ago, it is projected to reach maturity very soon and slip from its top position. On the other hand,
aggressive growth in Asian economies such as China, Singapore, India, and South Korea will lead to a shift
in the dynamics of the DNA microarray market. These markets are poised for massive growth as drug
discovery and clinical trials intensify here.
Vital aspects of value of the DNA gene chip market include a strong supply chain, world-class logistical
connectivity, cutting-edge scientific infrastructure, and the availability of skilled manpower. Singapore
boasts leadership on all these fronts, making it a hub for the DNA gene chip market. Most of the companies
are focing on setting up of facilities in this region due to strong intellectual property laws, logistics
connectivity and supply chain.
Growth in personalized medicines, rising prevalence of cancer, technology advancements and large scale
initiatives by the organization are some of the major drivers of this market. According to the World Health
Organization (WHO) worldwide 8.2 million people died of cancer in 2012. In 2013, American Cancer Society
(ACS) published that, around 300,000 men and 276,000 women died due to cancer in 2012 in the U.S.
Moreover, California Journal of Clinical Cancer (CJCC) stated that, one in the every six U.S. men have
received diagnosis test for prostate cancer at some point in their lives. Hence, such high prevalence of
diseased condition would raise the growth of the market to a higher end.
Some of the majors players of the DNA chip market include Affymetrix, Inc., Agilent Technologies,
Biomérieux Sa, Biometrix Technology Inc, Capitalbio Corporation, Bioneer Corporation, Eurofins Mwg
Operon, Illumina Inc., Greiner Bio-One, Lc Sciences, Life Technologies Corporation, Microarrays Inc,
Macrogen Inc, Sequenom Inc, Scienion Ag, Sigma-Aldrich, Savyon Diagnostics Ltd, Roche Nimblegen Inc,
Wafergen Biosystems Inc and others.
This research report analyzes this market on the basis of its market segments, major geographies, and
current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It
provides market projections for the coming years. It includes analysis of recent developments in
technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market players and new entrants
along with detailed value chain analysis.
Inquiry Before Buying:
Latest Press Release Reports:
Latest Articles Reports:
Read More Reports on Biotechnology Market:
About Us
Transparency Market Research (TMR) is a market intelligence company providing global business research
reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with
various tools and techniques to gather and analyze information. Our business offerings represent the latest
and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Mr. Nachiket Ghumare90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: [email protected]
shekharm18   documents Email
technical documentation
File Size
108 KB
Report inappropriate content